VEGF signaling has been identified as a key factor in the pathogenesis of sporadic colorectal tumors in mouse and man [25, 26], and both PGE2 and IL-17A are known to induce VEGF [27, 28]. This evidence concerns the gene IL17A and colorectal neoplasm.